Celularity (CELU) Operating Margin Growth (1y) (2021 - 2025)
Powered by 
Analysis
Celularity (CELU) Operating Margin Growth (1y) (2021 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.20 Bn | 9.35 Bn | 112.79 Mn | 798.00 |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - | 2.46 Mn |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn | 13,751.00 |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn | 2,348.00 |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | -6,012.00 |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | -2.44 Mn |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | 375,193.00 |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | -1,560.00 |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 377.00 |
| 10 | Celularity | 36.65 Mn | 30.48 Mn | -3.27 Mn | 81,136.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 81,136.00 |
| Sep 30, 2025 | -12,013.00 |
| Jun 30, 2025 | -19,255.00 |
| Mar 31, 2025 | -4,153.00 |
| Dec 31, 2024 | -145,877.00 |
| Sep 30, 2024 | 249,766.00 |
| Jun 30, 2024 | 136,173.00 |
| Mar 31, 2024 | 157,288.00 |
| Dec 31, 2023 | -31,354.00 |
| Sep 30, 2023 | -248,512.00 |
| Jun 30, 2023 | -155,631.00 |
| Mar 31, 2023 | -92,196.00 |
| Dec 31, 2022 | 73,136.00 |
| Sep 30, 2022 | -23,914.00 |
| Jun 30, 2022 | 200,644.00 |
| Mar 31, 2022 | 96,782.00 |
| Dec 31, 2021 | -64,878.00 |
| Sep 30, 2021 | 24,585.00 |